Combination therapy of the chimeric monoclonal anti-tumor necrosis factor α antibody (infliximab) with methotrexate in patients with rheumatoid arthritis

被引：0

作者：

Antoni, C ^{[1
]}

Kalden, JR ^{[1
]}

机构：

[1] Univ Erlangen Nurnberg, Inst Immunol & Rheumatol, Dept Med 3, D-91023 Erlangen, Germany

来源：

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 1999年 / 17卷 / 06期

关键词：

infliximab; methotrexate; tumor necrosis factor; combination treatment; rheumatoid arthritis; efficacy; side effects; immunogenecity;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Infliximab, a chimeric anti-TNF alpha antibody, showed in two double-blind placebo-controlled trials efficacy in combination with methotrexate (MTX) inpatients with severe rheumatoid arthritis (RA). Whereas in the first trial low-dose MIX or placebo was compared to infliximab alone and in combination, the second trial compared infliximab to placebo inpatients with active RA despite maximal tolerated MTX treatment. Infliximab showed synergistic effects in combination with MTX. The immunogenicity of infliximab was reduced by the combination. Infliximab in combination with high-dose MTX is effective and safe in long-term treatment up to 54 weeks.

引用

页码：S73 / S77

页数：5

共 50 条

[31] Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment? [J].

Takao Nagashima ;

Seiji Minota .

Clinical Rheumatology, 2010, 29 :819-820

[32] Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy [J].

Straub, RH ;

Härle, P ;

Atzeni, F ;

Weidler, C ;

Cutolo, M ;

Sarzi-Puttini, P .

JOURNAL OF RHEUMATOLOGY, 2005, 32 (07) :1253-1257

[33] Genetic predictors of response to anti-tumor necrosis factor drugs in rheumatoid arthritis [J].

Tan, Rachael ;

Barton, Anne .

RHEUMATOLOGY REPORTS, 2009, 1 (01) :1-4

[34] Anti-Tumor Necrosis Factor-alpha Therapy Provokes Latent Leishmaniasis in a Patient with Rheumatoid Arthritis [J].

Franklin, Gillian ;

Greenspan, Joel ;

Chen, Sheng .

ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2009, 39 (02) :192-195

[35] Rheumatoid Arthritis Risk Allele PTPRC Is Also Associated With Response to Anti-Tumor Necrosis Factor α Therapy [J].

Cui, Jing ;

Saevarsdottir, Saedis ;

Thomson, Brian ;

Padyukov, Leonid ;

van der Helm-van Mil, Annette H. M. ;

Nititham, Joanne ;

Hughes, Laura B. ;

de Vries, Niek ;

Raychaudhuri, Soumya ;

Alfredsson, Lars ;

Askling, Johan ;

Wedren, Sara ;

Ding, Bo ;

Guiducci, Candace ;

Wolbink, Gert Jan ;

Crusius, J. Bart A. ;

van der Horst-Bruinsma, Irene E. ;

Herenius, Marieke ;

Weinblatt, Michael E. ;

Shadick, Nancy A. ;

Worthington, Jane ;

Batliwalla, Franak ;

Kern, Marlena ;

Morgan, Ann W. ;

Wilson, Anthony G. ;

Isaacs, John D. ;

Hyrich, Kimme ;

Seldin, Michael F. ;

Moreland, Larry W. ;

Behrens, Timothy W. ;

Allaart, Cornelia F. ;

Criswell, Lindsey A. ;

Huizinga, Tom W. J. ;

Tak, Paul P. ;

Bridges, S. Louis, Jr. ;

Toes, Rene E. M. ;

Barton, Anne ;

Klareskog, Lars ;

Gregersen, Peter K. ;

Karlson, Elizabeth W. ;

Plenge, Robert M. .

ARTHRITIS AND RHEUMATISM, 2010, 62 (07) :1849-1861

[36] Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot study [J].

Weisman, MH ;

Moreland, LW ;

Furst, DE ;

Weinblatt, ME ;

Keystone, EC ;

Paulus, HE ;

Teoh, LS ;

Velagapudi, RB ;

Noertersheuser, PA ;

Granneman, GR ;

Fischkoff, SA ;

Chartash, EK .

CLINICAL THERAPEUTICS, 2003, 25 (06) :1700-1721

[37] Genotoxicity of Anti-Tumor Necrosis Factor Therapy in Patients With Juvenile Idiopathic Arthritis [J].

Demirkaya, Erkan ;

Cok, Ismet ;

Durmaz, Emre ;

Ulutas, Onur K. ;

Ayaz, Nuray Aktay ;

Besbas, Nesrin ;

Ozen, Seza .

ARTHRITIS CARE & RESEARCH, 2010, 62 (01) :73-77

[38] Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial [J].

Fleischmann, RM ;

Cohen, SB ;

Moreland, LW ;

Schiff, M ;

Mease, PJ ;

Smith, DB ;

Keenan, G ;

Kremer, JM .

CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) :1181-1190

[39] Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis [J].

Tilg, H ;

Jalan, R ;

Kaser, A ;

Davies, NA ;

Offner, FA ;

Hodges, SJ ;

Ludwiczek, O ;

Shawcross, D ;

Zoller, H ;

Alisa, A ;

Mookerjee, RP ;

Graziadei, N ;

Datz, C ;

Trauner, M ;

Schuppan, D ;

Obrist, P ;

Vogel, W ;

Williams, R .

JOURNAL OF HEPATOLOGY, 2003, 38 (04) :419-425

[40] Anti-tumor necrosis factor therapy in rheumatoid arthritis patients with a history of deep prosthetic joint infection: a report of four cases [J].

Hirano, Yuji ;

Kojima, Toshihisa ;

Kanayama, Yasuhide ;

Shioura, Tomone ;

Hayashi, Masatoshi ;

Tsuboi, Seiji ;

Ishiguro, Naoki .

MODERN RHEUMATOLOGY, 2011, 21 (05) :542-547

← 1 2 3 4 5 →